(Q39672736)

13 September 2017

title

The antiangiogenic efficacy of NGR-modified PEG-DSPE micelles containing paclitaxel (NGR-M-PTX) for the treatment of glioma in rats (English)

1 reference

13 September 2017

The antiangiogenic efficacy of NGR-modified PEG–DSPE micelles containing paclitaxel (NGR-M-PTX) for the treatment of glioma in rats (English)

1 reference

https://api.crossref.org/works/10.3109/1061186X.2010.504267

15 June 2024

main subject

micelles

0 references

angiogenesis inhibitor

1 reference

1 reference

Bo-Jun Zhao

1

1 reference

13 September 2017

Xi-Yu Ke

2

1 reference

13 September 2017

Yue Huang

3

1 reference

13 September 2017

Xiao-Mei Chen

4

1 reference

13 September 2017

Xin Zhao

5

1 reference

13 September 2017

Bing-Xiang Zhao

6

1 reference

13 September 2017

Wan-liang Lu

7

1 reference

13 September 2017

Jin-Ning Lou

8

1 reference

13 September 2017

Xuan Zhang

9

1 reference

13 September 2017

Qiang Zhang

10

1 reference

13 September 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20677914

15 June 2024

publication date

2 August 2010

1 reference

full work available at URL

13 September 2017

http://www.tandfonline.com/doi/pdf/10.1080/10256018808623883

1 reference

https://api.crossref.org/works/10.3109/1061186X.2010.504267

Journal of Drug Targeting

15 June 2024

published in

1 reference

13 September 2017

volume

19

1 reference

13 September 2017

issue

5

1 reference

13 September 2017

page(s)

382-390

1 reference

Fighting cancer by attacking its blood supply

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.504267

A new approach to fighting cancer?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.504267

Active targeting schemes for nanoparticle systems in cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.504267

Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.504267

Irreversible inhibition of CD13/aminopeptidase N by the antiangiogenic agent curcumin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.504267

A doxorubicin-CNGRC-peptide conjugate with prodrug properties

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.504267

Anti-cancer activity of targeted pro-apoptotic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.504267

Binding and internalization of NGR-peptide-targeted liposomal doxorubicin (TVT-DOX) in CD13-expressing cells and its antitumor effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.504267

Progenitor cells and glioma formation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.504267

PPARgamma-dependent effects of conjugated linoleic acid on the human glioblastoma cell line (ADF).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.504267

Brain cancer diagnosis and therapy with nanoplatforms

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.504267

BBB-Genomics: creating new openings for brain-drug targeting.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.504267

Antiangiogenesis -- therapeutic strategies and clinical implications for brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.504267

Taxol: a novel investigational antimicrotubule agent

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.504267

Cremophor EL: the drawbacks and advantages of vehicle selection for drug formulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.504267

Taxane-mediated antiangiogenesis in vitro: influence of formulation vehicles and binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.504267

Paclitaxel delivery from PLGA foams for controlled release in post-surgical chemotherapy against glioblastoma multiforme.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.504267

Biodegradable microfiber implants delivering paclitaxel for post-surgical chemotherapy against malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.504267

Effect of the lipid chain melting transition on the stability of DSPE-PEG(2000) micelles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.504267

Sulforhodamine B colorimetric assay for cytotoxicity screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.504267

Local chemotherapy of F98 rat glioblastoma with paclitaxel and carboplatin embedded in liquid crystalline cubic phases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.504267

Neuroprotective effects of citicoline on brain edema and blood-brain barrier breakdown after traumatic brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.504267

Drug targeting to the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.504267

Anti-angiogenic treatment strategies for malignant brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.504267

Neovascular targeting chemotherapy: encapsulation of paclitaxel in cationic liposomes impairs functional tumor microvasculature

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.504267

Tumor-selective vessel occlusions by platelets after vascular targeting chemotherapy using paclitaxel encapsulated in cationic liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.504267

Paclitaxel encapsulated in cationic liposomes increases tumor microvessel leakiness and improves therapeutic efficacy in combination with Cisplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.504267

Long-circulating poly(ethylene glycol)-poly(D,L-lactide) block copolymer micelles with modulated surface charge

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F1061186X.2010.504267

Development of amphiphilic diblock copolymers as micellar carriers of taxol

21 January 2018

26

1 reference

https://api.crossref.org/works/10.3109/1061186X.2010.504267

Effect of a novel vacuolar-H+-ATPase inhibitor on cell and tumor response to camptothecins

15 June 2024

30

1 reference

https://api.crossref.org/works/10.3109/1061186X.2010.504267

In vitro and in vivo studies on plasma-to-blood ratio of paclitaxel in human, rabbit and rat blood fractions

15 June 2024

31

1 reference

https://api.crossref.org/works/10.3109/1061186X.2010.504267

Paclitaxel encapsulated in cationic liposomes diminishes tumor angiogenesis and melanoma growth in a "humanized" SCID mouse model

15 June 2024

34

1 reference

https://api.crossref.org/works/10.3109/1061186X.2010.504267

15 June 2024

Identifiers

1 reference

13 September 2017

1 reference